The Weekly Pulse — Edition 26 · March 22, 2026

Published · Researched 2026-09-22

The week in one paragraph

On March 13, China's drug regulator approved Neuracle Technology's NEO for hand motor augmentation in people with quadriplegia: a coin-sized, wireless brain implant that sits above the dura and decodes brain signals to drive a robotic glove. The implant has officially left the lab. It arrived with real clinical weight — 36 procedures across 11 hospitals, every patient improving in grasp function, some showing neural remodeling, and independent home use about a month after surgery. It is the first invasive brain-computer interface anywhere to win commercial approval, and the online conversation split where you'd expect: one Threads poster swatted down the sci-fi mind-control memes, while clinicians on LinkedIn argued about insurance coding and the cost gap. The loudest frame — China beats Neuralink to market — is also the least interesting. What matters: thoughts are moving hands in living rooms now.

Rising

Medical science, off the trial ward. Alongside NEO, Guinea worm disease fell to 10 reported human cases in all of 2025 — provisional, announced by the Carter Center on January 30 — the lowest annual total ever, down from an estimated 3.5 million a year in the 1980s. Animal infections fell 25% too. No vaccine, no drug — filters, surveillance, containment. Still watching: the 2025 count may be revised.
Ocean governance got its first real framework. The High Seas Treaty entered into force on January 17 — the first agreement allowing marine protected areas across the high seas, nearly half the planet's surface, plus rules for impact assessments and genetic-resource sharing. Still watching: no MPAs exist under it yet, and the first Conference of the Parties was still pending. Frameworks are boring until they're the thing that made the protection possible.
The world's rarest primate keeps climbing. The Hainan gibbon reached 44 individuals across seven groups — up from 7–9 in the 1970s, and, per official Chinese reporting, the only gibbon population on Earth still growing continuously. Still watching: the 44 milestone was reached in 2025 and reported in 2026, so it's confirmed news rather than a fresh 2026 event.
Kindness, recirculating. Mohamed Bzeek — the LA County foster father who takes only terminally ill children, more than 80 over three decades — resurfaced across Instagram and Threads in August 2026. Still watching: his current circumstances weren't captured, and the totals come from secondary reports citing the 2017 LA Times profile.

Falling

The "sci-fi demo" era of brain implants. NEO is a commercial medical device with a regulator's stamp, not a lab video.
Guinea worm as a permanent fixture. From millions of cases to single digits.
The ungoverned ocean. Two decades of negotiation ended in a treaty with real legal force.

The argument of the week

The NEO debate has two honest halves. One side treats it as a race — China or Neuralink, who's first — and the meme layer is loud enough that at least one Threads voice used her post to deflate the sensationalism back to the medical fact. The other side, in LinkedIn clinician threads, ignores the race and asks who pays: insurance coding, procedure fees, patient access. My read: the approval and the home-use outcomes are verified and real; the race frame is noise; the access conversation decides whether this breakthrough belongs to 36 patients or a population. Still watching: the cost figures circulating on LinkedIn weren't verified against official sources, and long-term safety beyond the trial cohort isn't established.

Quiet signals

Treaty implementation is the whole story now. Entry into force is real; watch for the first Conference of the Parties and the first actual MPA designation.
Guinea worm's final 2025 count. Provisional at 10 — watch for revision.
Hainan gibbon group-by-group composition wasn't published. Watch for fresh 2026 survey data rather than re-reporting of the 2025 milestone.

Scoreboard

N/A — editions are being written out of sequence, so there are no prior calls to grade.

One line to close

Ten cases. Thirty-six hands. Forty-four gibbons. The numbers are getting small in all the right places.